DOHLER ON【DOHL3】銘柄情報 | ADVFN

US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
ブラジル
BOV
Dohler Sa (DOHL3) 銘柄情報

Dohler Sa (DOHL3)

10.17

0.00

(0.00%)

終了 9月27日 5:55AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

10.17

買値

0.00

売値

0.00

出来高

-

0.00 日の範囲 0.00

5.01 52 週間の範囲 12.80

時価総額

前日終値

10.17

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

-

発行済株式数

54,467,820

配当利回り

-

PER

1,182.56

1 株当たり利益 (EPS)

0.01

歳入

759.1M

純利益

467k

セクター

Textile Goods, Nec

業界

Textile Goods, Nec

ウェブサイト

www.dohler.com.br

本社

Joinville, Santa Catarina, Bra

設立

-

Dohler Sa is listed in the Textile Goods sector of the ボベスパ (ブラジル) with ticker DOHL3. The last closing price for DOHLER ON was R$10.17. Over the last year, DOHLER ON shares have traded in a share price range of R$ 5.01 to R$ 12.80.

DOHLER ON currently has 54,467,820 shares in issue. The market capitalisation of DOHLER ON is R$553.94 million. DOHLER ON has a price to earnings ratio (PE ratio) of 1182.56.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	3.68	56.7026194145	6.49	12.8	5.01	257	7.03111111	CS
52	2.67	35.6	7.5	12.8	5.01	224	7.02135135	CS
156	-9.83	-49.15	20	20	5.01	217	10.77545455	CS
260	0.17	1.7	10	65	5.01	1507	24.96724834	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
AZUL4AZUL SA	R$ 5.60 (9.80%)	38.93k
CSNA3Cia Siderurgica Nacional	R$ 13.23 (8.89%)	37.1k
SEQL3Sequoia Logistica e Transportes SA	R$ 4.65 (8.64%)	64.13k
NORD3Nordon Inds Metalurgicas Sa	R$ 10.84 (8.40%)	100
COGN3CognaEducacao SA	R$ 1.34 (8.06%)	55.22k
PDGR3PDG Realty S.A. Empreendimentos E Participacoes	R$ 0.02 (-60.00%)	19.7k
BIOM11Biomm SA	R$ 0.59 (-24.36%)	4.7k
HETA4Hercules SA Fabrica De Talheres	R$ 6.22 (-11.02%)	400
DASA11Diagnosticos da America SA	R$ 1.40 (-6.67%)	100
CCRO3QCCR SA	R$ 12.55 (-6.34%)	242.6k
SRNA3Serena Energia S.A.	R$ 8.28 (-0.84%)	1.55M
VITT3Vittia S.A.	R$ 5.60 (-0.18%)	883.9k
IFCM11Infracommerce Caxaas S.A.	R$ 0.03 (0.00%)	862.6k
SYNE3SYN Prop E Tech S.A	R$ 7.77 (0.91%)	762k
ORVR3Orizon Valorizacao De Residuos SA	R$ 48.71 (-0.81%)	739k

Risk

This is awesome. Thanks TJ. Need a lot of patience.

nidan7500

nidan7500 4分前

georgejjiUS FDA approves Bristol Myers' schizophrenia drug

FDA approval for new type of schizophrenia treatment

ristol prices drug at $1,850 a month

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-bristol-myers-schizophrenia-dr

RobotDroid

RobotDroid 4分前

Another wrong opinion. Too funny how the cult looks at other companies data and thinks it applies to nwbo. It doesn't, no other compnay has the worst, inept mute mismanagement clown show in history.

Risk

TJ that’s better dream :)) OS dream big :))

Wingsjr

Wingsjr 5分前

Thx, brother. 👍

Golden Cross

Golden Cross 6分前

$XXII New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile
https://www.newsfilecorp.com/release/224193/22nd-Century-Announces-New-Branded-Products-Order-with-Customer-for-Southeast-Asi

GetSeriousOK

GetSeriousOK 6分前

Call her then.

And don't accept "we'll release a PR when it's appropriate" for an answer.

Personally, I wouldn't believe anything she told you over the phone, but that's just my experience with biotech CEO phone calls. Whatever she says, tell her "Put that in writing.

Golden Cross

Golden Cross 7分前

$XXII New Customer for 22nd Century's Internally Owned Moonlight Brand Could Increase Factory Volumes by More Than 30% When Fully Scaled, Improve Gross Profit Profile
https://www.newsfilecorp.com/release/224193/22nd-Century-Announces-New-Branded-Products-Order-with-Customer-for-Southeast-Asi

weedtrader420

weedtrader420 7分前

XRP✊😎 Lynyrd Skynyrd SIMPLE MAN $1 TARGET

MFranny

MFranny 7分前

That's where, at the very least, Steven Walker should have been present. But he wasn't...

GetSeriousOK

GetSeriousOK 8分前

Sorry, the patents expired due to non-payment of maintenance fees.

"Extended to 2029" refers to the Patent Term Restoration (PTR) extension. IF Whelan had paid the maintenance fees, the patents would be active until 2029. Without that extension they would have expired in 2023, twenty

manibiotech

manibiotech 8分前

In that case they will have to take personal responsibility and be held accountable . Current strategy transfers 100% of responsibility and blame on someone else . So what’s the incentive to change ?

zj3001

$RNAZ everyone so focused on a price per share, but no one ever talks about market cap. Imagine Transcode getting a $50-200m upfront payment to partner with Big Pharma. What do you think that makes the value of the company?

What if they get fda fast track approval?

It

Alexulf

Alexulf 8分前

We continue the climb up!

Strong news do the trick :-)

https://aitx.ai/

MetaMonster

MetaMonster 9分前

Ceo Mark White is in rehab for drug addiction

FeMike

That's just a guess, and probably wrong.
You realize you are an absolute moron, right? 3 months ago after the ASM, when I said we hadn't gotten an RFI yet and were still in phase 1, you told me that was "100% not true". When i asked you to clarify, you said:
We are not in phase 1. Th

James56

James56 9分前

2020trader

2020trader 9分前

that would be a wasted call...lol

1vman

*****Wowzah🟥🟥🟥🟥 Power2theGMEshorters/brilliant, interest has faded big time here

ENOUGH SAID

arachnodude

arachnodude 9分前

Consider demand influences the rate at which they produce, but the capacity reflects what the facility is capable of producing under optimal conditions, regardless of how much is currently being ordered or sold.

kid70

Hopefully, we can beat yesterday volume. Lol

Deano361

Deano361 10分前

Now from 100 to 500m?

European Investment Bank

Banco Comercial Portugues (PK)

Hsbc Usa Inc Capped Dual...

NLBNPIT1VV67 20991231 18...

China Everbright Bank (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約